After 478% Increase In Q1 Patients, Empower Clinics Adds Telemedicine Access To Physicians and E-Commerce

With 165,000 patients, Empower Clinics (CBDT:CSE) (EPWCF:OTCQB) has a database that almost every medical cannabis and CBD company would  kill for.  Patient visits increased 800% in February. 590% in March and  480% for Q1.  But will Coronavirus social gathering imitations put the  clinic network at risk?

No.  In fact, it has had the opposite effect, with the clinics being  designated an essential service.  Moreover, Empower had to actually  increase operating hours due to demand from existing patients who need  their CBD medication more than ever, as well as, new patients who are  experiencing anxiety and stress through the COVID-19 pandemic.

BUT THAT WASN’T ENOUGH

The Company has now entered expanded into telemedicine across  multiple states for patients who can’t get to a clinic but need a  consultation with doctors over the phone to determine the best CBD  medications, as well as, 250 new homeopath products for their newly  launched immunotherapy initiative …. all which can be fulfilled through  the company’s e-commerce platform.

Oh …. and did we mention that psychedelics are on the way?  Empower  Clinics has already announced its intention to expand into the field of  Psilocybin and psychedelics.  The new telemedicine platform now  accelerates this initiative.

Watch this interview with the Company’s CEO, Steven McAuley, who is  Six Sigma certified under the quality initiative of legendary GE  chairman Jack Welch. We’ve never seen a Six Sigma certified CEO in the  Canadian small cap markets. Never …. which also explains how McAuley has  been able to guide Empower Clinics through the most disruptive retail  environment in recent history and turn it into real growth.

Grab your favourite beverage and settle in to watch what may be your next great small cap investment